Description: Feature article focuses on the regulators who determine risk-based capital or RBC standards applicable to health plans.

Description: With the medical insurance market experiencing health care inflation of 10 to 13 percent and medical costs averaging above $8,000 per year per employee less for single employees and more for employees with families, employers are looking at alternative options. Politicians and regulators are as well.

Description: Provider Excess is an insurance coverage offered to health care provider organizations that have a capitation agreement with a manged care organization. From Reinsurance Section News, November 2007, Issue No. 61.

Description: Chapter 4 analyzes, in table form, the study's claimant counts and charges in excess of deductible, broken down by deductible level, geographic region, age, gender, and subscriber vs. dependent status. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: this article provides an overview of coverage and claim trends for managed care medical excess of loss insurance and reinsurance programs. it addresses features such as deductible, maximum benefit, inside limits , comprehensive versus non- comprehensive , and claims by diagnosis for commercial , Medicare and Medicaid risk. It also reviews cost containment support programs for catastrophic claims .

Description: Excess Reinsurance is a coverage purchased by insurance carriers to limit loss in a year from any one claim. This article addresses the issues when purchasing medical excess reinsurance on a medical portfolio. The most important consideration in the reinsurance purchasing decision is determining the risk objectives of the organization. The proper risk analysis by the carrier or in conjunction with its reinsurer will address the following questions: What is predictable risk versus unpredictable risk?

Description: Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are being cured. These are great for individuals and society, but the treatment costs are expensive which is bad for payers and reinsurers. This article explores ways for health reinsurance actuaries to participate in the space and evaluate the risk associated with these treatments

Description: Chapter 3 analyzes, in table form, the study's claimant counts and charge totals, broken down by plan design type, gender, age, year, and by subscriber vs. dependent. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: Chapter 7 analyzes, in table form, the study's claimant counts & charges per claimant in relation to deductible and broken down by diagnosis category. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.

Description: Chapter 8 analyzes, in table form, exposure in relation to status, gender, age range, and deductible level. From Group Medical Insurance Large Claims Database Collection and Analysis, M-HB97-1.